Pursuant to provisions of the act on reimbursement, a rationalisation analysis must be developed when the conducted budget impact analysis indicates increased cost of financing the considered health technology. The aim of the rationalisation analysis is to present solutions which would allow for financing of a new technology without incurring additional costs to be borne by the public payer.